
   
   
      
         
            The_DT Hunger_NNP

            "_'' Food_NNP is_VBZ
not_RB the_DT boss_NN in_IN my_PRP$ life_NN ._. I_PRP am_VBP stronger_JJR than_IN the_DT temptation_NN of_IN any_DT food_NN ._. "_''

            
               -_: -_: from_IN
the_DT Richard_NNP Simmons_NNP home_NN page_NN
            

            Then_RB again_RB ,_, maybe_RB not_RB ._.
Americans_NNPS spend_VBP $_$ 30_CD billion_CD a_DT year_NN on_IN weight-loss_JJ programs_NNS ,_, but_CC obesity_NN resists_VBZ
treatment_NN more_RBR tenaciously_RB than_IN do_VBP viruses--_JJ 90_CD percent_NN to_TO 95_CD percent_NN of_IN people_NNS
who_WP lose_VBP weight_NN eventually_RB regain_VB it_PRP ._.

            Why_WRB is_VBZ
that_DT ?_. We_PRP 've_VBP learned_VBN much_JJ in_IN the_DT last_JJ few_JJ years_NNS about_IN the_DT role_NN that_DT hunger_NN plays_VBZ
in_IN obesity_NN ._. Drug_NN companies_NNS have_VBP capitalized_VBN on_IN that_DT knowledge_NN to_TO create_VB
powerful_JJ new_JJ appetite_NN suppressants_NNS ._. But_CC these_DT "_'' cures_NNS "_'' come_VB with_IN serious_JJ risks_NNS ._.
Researchers_NNS linked_VBD the_DT popular_JJ diet-drug_JJ combination_NN "_'' fen-phen_JJ "_'' to_TO a_DT rare_JJ heart_NN
disease_NN a_DT year_NN ago_RB ._. But_CC doctors_NNS continued_VBD to_TO prescribe_VB it_PRP to_TO millions_NNS ,_, arguing_VBG
that_IN the_DT health_NN risks_NNS associated_VBN with_IN obesity_NN justified_JJ fen-phen_JJ 's_POS wide_JJ use_NN ._.
Now_RB reports_VBZ of_IN new_JJ heart_NN abnormalities_NNS in_IN women_NNS on_IN fen-phen_JJ raise_NN fresh_JJ
questions_NNS about_IN using_VBG pills_NNS for_IN obesity_NN before_IN all_PDT the_DT facts_NNS are_VBP in_IN ._.

            Scientists_NNS did_VBD n't_RB always_RB view_VB appetite_NN as_IN a_DT cause_NN of_IN
obesity_NN ._. The_DT dominant_JJ thinking_NN for_IN more_JJR than_IN two_CD decades_NNS was_VBD that_IN the_DT obese_NN
gained_VBD weight_NN because_IN they_PRP burned_VBD fewer_JJR calories_NNS ._. In_IN experiments_NNS ,_, overfed_JJ or_CC
underfed_JJ volunteers_NNS always_RB returned_VBD to_TO their_PRP$ original_JJ weight--the_JJ
"_'' setpoint_NN "_'' -_: -_: when_WRB they_PRP ceased_VBD their_PRP$ diets_NNS ._. Also_RB ,_, when_WRB obese_NN dieters_NNS lost_VBD weight_NN ,_,
their_PRP$ metabolism_NN slowed_VBD ,_, conserving_VBG calories_NNS and_CC driving_VBG their_PRP$ weight_NN back_RB to_TO
the_DT setpoint_NN ._. It_PRP seemed_VBD that_IN obese_NN people_NNS 's_POS only_RB option_NN was_VBD a_DT combination_NN of_IN
starvation_NN and_CC exercise_NN ,_, while_IN skinny_NN people_NNS got_VBD to_TO feast_NN and_CC watch_VB television_NN ._.
In_IN the_DT late_JJ '_POS 60_CD s_VBZ ,_, amphetamine_NN ,_, which_WDT increases_VBZ metabolism_NN ,_, became_VBD the_DT rage_NN for_IN
dieters_NNS ._. But_CC it_PRP did_VBD n't_RB keep_VB the_DT weight_NN off_RP ,_, and_CC proved_VBD to_TO be_VB addictive_JJ ._.

            As_IN it_PRP
turned_VBD out_IN ,_, thin_JJ people_NNS did_VBD n't_RB have_VB higher_JJR metabolic_JJ rates_NNS ._. On_IN high-calorie_JJ
diets_NNS ,_, they_PRP gained_VBD weight_NN just_RB as_RB easily_RB as_IN obese_NN people_NNS ._. (_( In_IN fact_NN ,_, obese_NN
people_NNS had_VBD to_TO eat_VB more_JJR to_TO put_VB on_IN a_DT given_VBN amount_NN of_IN weight_NN ._. )_) The_DT
metabolism_NN of_IN obese_NN dieters_NNS never_RB slowed_VBD enough_RB to_TO explain_VB how_WRB quickly_RB their_PRP$
weight_NN bounced_VBD back_RB ._. They_PRP were_VBD also_RB eating_VBG more_JJR ._. Put_VB simply_RB ,_, even_RB at_IN their_PRP$
baseline_NN weight_NN ,_, obese_NN people_NNS eat_VBP more_JJR than_IN thin_JJ people_NNS ._.

            
Swedish_JJ studies_NNS of_IN pregnant_JJ women_NNS demonstrate_VBP
this_DT observation_NN ._. Women_NNP weighed_VBD about_IN a_DT pound_NN more_JJR one_CD year_NN after_IN delivery_NN than_IN
at_IN the_DT start_NN of_IN pregnancy_NN ._. Some_DT gained_VBD more_JJR than_IN a_DT pound_NN ,_, and_CC many_JJ returned_VBD to_TO
their_PRP$ old_JJ weight_NN ._. How_WRB were_VBD the_DT gainers_NNS different_JJ from_IN the_DT non-gainers_JJ ?_. Mainly_RB ,_,
they_PRP ate_VBD more_RBR total_JJ calories_NNS ,_, especially_RB in_IN the_DT form_NN of_IN snacks_NNS ._. Although_IN
gainers_NNS ate_VBD lunch_NN less_RBR often_RB ,_, their_PRP$ snacking_VBG increased_VBN to_TO three_CD or_CC more_JJR times_NNS
per_IN day_NN ._.

            The_DT study_NN
also_RB demonstrated_VBD another_DT frustrating_JJ fact_NN about_IN setpoints--they_JJ 're_VBP easier_JJR to_TO
increase_VB than_IN decrease_VB ._. Experts_NNS believe_VBP that_IN once_RB you_PRP 've_VBP put_VBN on_IN extra_JJ weight_NN
for_IN six_CD months_NNS to_TO a_DT year_NN ,_, the_DT setpoint_NN resets_NNS ,_, as_IN it_PRP does_VBZ after_IN pregnancy_NN ._. To_TO
permanently_RB lower_VB the_DT setpoint_NN ,_, you_PRP must_MD keep_VB weight_NN off_RP for_IN about_IN three_CD years_NNS ,_,
perhaps_RB longer_RBR ._. Until_IN recently_RB ,_, nothing_NN short_JJ of_IN has_VBZ kept_VBN the_DT seriously_RB obese_NN
from_IN eating_VBG as_RB much_JJ as_IN they_PRP want_VBP to_TO ._.

            The_DT big_JJ breakthrough_NN in_IN understanding_NN obesity_NN came_VBD in_IN 1994_CD ,_,
when_WRB experiments_NNS on_IN lab_NN mice_NNS revealed_VBD that_IN the_DT hormone_NN leptin_NN controls_VBZ the_DT
setpoint_NN by_IN controlling_VBG satiety_NN ._. When_WRB your_PRP$ weight_NN falls_VBZ ,_, leptin_NN decreases_NNS ,_,
hunger_NN increases_NNS ,_, and_CC you_PRP eat_VBP more--until_JJ you_PRP return_VBP to_TO your_PRP$ weight_NN setpoint_NN ._.
This_DT year_NN ,_, researchers_NNS in_IN Cambridge_NNP ,_, England_NNP ,_, found_VBD an_DT inbred_JJ family_NN whose_WP$
members_NNS all_DT lacked_VBD the_DT gene_NN for_IN producing_VBG leptin_NN ._. Without_IN leptin_NN to_TO signal_VB
satiety_NN ,_, the_DT children_NNS in_IN this_DT family_NN eat_VB ravenously_RB ._. The_DT 2_CD -_: year-old_JJ weighs_VBZ 64_CD
pounds_NNS and_CC the_DT 8_CD -_: year-old_JJ ,_, 189_CD pounds_NNS ._.

            These_DT
leptin_NN findings_NNS imply_VBP that_IN hormones_NNS and_CC neurotransmitters_NNS control_VBP the_DT
instinctual_NN desire_NN to_TO eat_VB ,_, overwhelming_JJ willpower_NN in_IN the_DT process_NN ._. In_IN
evolutionary_JJ terms_NNS ,_, this_DT makes_VBZ sense_NN ._. The_DT drive_NN to_TO find_VB and_CC eat_VB food_NN was_VBD
integral_JJ to_TO the_DT survival_NN of_IN our_PRP$ early_JJ ancestors_NNS ._. People_NNS who_WP gorged_JJ themselves_PRP
survived_VBD winter_NN famines_NNS and_CC reproduced_VBD more_JJR than_IN others_NNS ._. But_CC this_DT behavior_NN
became_VBD "_'' maladaptive_JJ "_'' when_WRB access_NN to_TO round-the-clock_JJ hamburgers_NNS and_CC ice_NN cream_NN
became_VBD the_DT norm_NN ._. Now_RB ,_, as_IN we_PRP gain_VBP weight_NN and_CC push_VB our_PRP$ setpoints_NNS upward_RB ,_, we_PRP are_VBP
reprogrammed_JJ to_TO eat_VB even_RB more_JJR ._.

            
The_DT leptin_NN breakthrough_NN spurred_VBD efforts_NNS to_TO
manipulate_VB the_DT brain_NN 's_POS hunger_NN centers_NNS ._. In_IN 1995_CD ,_, a_DT combination_NN of_IN two_CD drugs_NNS ,_,
fenfluramine_NN and_CC phentermine--fen-phen--was_JJ shown_VBN to_TO suppress_VB appetite_NN enough_RB
to_TO help_VB the_DT severely_RB obese_NN lose_VBP an_DT average_NN of_IN 24_CD pounds_NNS after_IN two_CD years_NNS ._.
Fenfluramine_NNP increases_VBZ the_DT brain_NN 's_POS serotonin_NN levels_NNS (_( Prozac_NNP does_VBZ ,_, too_RB ,_, but_CC not_RB
as_RB dramatically_RB )_) to_TO produce_VB a_DT sense_NN of_IN satiety_NN ._. Phentermine_NNP is_VBZ a_DT relative_NN of_IN
amphetamine_NN that_WDT reduces_VBZ hunger_NN and_CC increases_NNS metabolism_NN ._. Not_RB surprisingly_RB ,_,
when_WRB the_DT obese_NN patients_NNS stopped_VBD taking_VBG these_DT drugs_NNS ,_, their_PRP$ weights_NNS returned_VBD to_TO
baseline_NN levels_NNS ._. But_CC fen-phen_JJ was_VBD the_DT first_JJ drug_NN therapy_NN proven_VBN to_TO reduce_VB
weight_NN over_IN the_DT long_JJ haul_NN ._.

            Other_JJ
drugs_NNS for_IN the_DT hyperhungry_NN are_VBP on_IN the_DT way_NN ._. Dexfenfluramine_NNP (_( tradenamed_JJ Redux_NNP )_) ,_, a_DT
cousin_NN of_IN fenfluramine_NN ,_, was_VBD just_RB released_VBN ._. Sibutramine_NNP ,_, with_IN fen-phen_JJ 's_POS effects_NNS
in_IN one_CD pill_NN ,_, and_CC orlistat_NN ,_, which_WDT prevents_VBZ fat_JJ absorption_NN from_IN the_DT intestines_NNS ,_,
are_VBP undergoing_VBG Food_NNP and_CC Drug_NNP Administration_NNP approval_NN testing_NN ._. Leptin_NNP analogues_NNS
(_( chemical_NN cousins_NNS )_) are_VBP also_RB being_VBG developed_VBN ._. Effective_NNP hunger_NN control_NN will_MD
probably_RB require_VB lifelong_JJ therapy_NN with_IN multiple_JJ drugs_NNS like_IN these_DT ._.

            The_DT first_JJ warning_NN that_IN these_DT drugs_NNS could_MD pose_VB health_NN risks_NNS
came_VBD a_DT year_NN ago_RB ,_, when_WRB the_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP published_VBD an_DT
article_NN by_IN French_JJ researchers_NNS linking_VBG fen-phen_JJ to_TO a_DT deadly_JJ cardiac_JJ disease_NN
called_VBD primary_JJ pulmonary_JJ hypertension_NN ._. The_DT study_NN suggested_VBD that_IN between_IN 23_CD and_CC
46_CD of_IN every_DT 1_CD million_CD patients_NNS taking_VBG fen-phen_JJ would_MD die_VB from_IN the_DT condition_NN
each_DT year_NN ._. (_( At_IN my_PRP$ hospital_NN ,_, a_DT young_JJ woman_NN died_VBD from_IN it_PRP after_IN taking_VBG fen-phen_JJ
for_IN 24_CD days_NNS to_TO lose_VB weight_NN for_IN her_PRP$ wedding_NN ._. )_) Yet_RB ,_, the_DT New_NNP England_NNP Journal_NNP of_IN
Medicine_NNP downplayed_VBD the_DT risks_NNS at_IN the_DT time_NN ._. It_PRP simultaneously_RB published_VBD an_DT
editorial_NN speculating_VBG that_IN fen-phen_JJ would_MD save_VB more_JJR lives_NNS by_IN reducing_VBG obesity_NN
than_IN the_DT associated_VBN heart_NN disease_NN would_MD kill_VB ._.

            The_DT French_JJ
findings_NNS were_VBD basically_RB ignored_VBN :_: Eighteen_CD million_CD prescriptions_NNS were_VBD filled_VBN for_IN
fen-phen_JJ in_IN the_DT United_NNP States_NNPS last_JJ year_NN ._. Physicians_NNPS opened_VBD offices_NNS and_CC Internet_NN
sites_NNS to_TO do_VB nothing_NN but_CC prescribe_VB fen-phen_JJ ,_, and_CC weight-loss_JJ operations_NNS like_IN
Jenny_NNP Craig_NNP and_CC Nutri_NNP /_NN System_NNP placed_VBD fen-phen_JJ prescription-writing_JJ doctors_NNS at_IN
the_DT center_NN of_IN their_PRP$ programs_NNS ._.

            
Fen-phen_NNP consumption_NN began_VBD to_TO fall_VB only_RB this_DT
month_NN ,_, when_WRB the_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP essentially_RB withdrew_VBD its_PRP$
earlier_RBR cost-benefit_JJ argument_NN with_IN the_DT emergency_NN release_NN of_IN startling_JJ new_JJ
fen-phen_JJ findings_NNS ._. Researchers_NNS in_IN Minnesota_NNP and_CC Nebraska_NNP documented_VBN 24_CD cases_NNS of_IN
unusual_JJ heart-valve_JJ abnormalities_NNS in_IN women_NNS taking_VBG fen-phen_JJ ._. The_DT average_JJ age_NN of_IN
the_DT patients_NNS was_VBD 43_CD ,_, and_CC five_CD required_VBN valve-replacement_JJ surgery_NN ._. This_DT week_NN ,_,
the_DT FDA_NNP reported_VBD 58_CD new_JJ cases_NNS of_IN abnormal_JJ heart_NN valves_NNS in_IN patients_NNS on_IN fen-phen_JJ ,_,
and_CC the_DT Journal_NNP of_IN the_DT American_NNP Medical_NNP Association_NNP reported_VBD animal_NN
evidence_NN linking_VBG both_DT dexfenfluramine_NN and_CC fenfluramine_NN to_TO toxic_JJ brain_NN
effects_NNS ._.

            There_EX are_VBP three_CD reasons_NNS why_WRB
nobody_NN should_MD have_VB bought_VBN the_DT obesity-is-deadlier_JJ argument_NN ._. 1_LS )_) Obesity_NNP 's_POS risks_NNS
come_VBP from_IN high_JJ blood_NN pressure_NN ,_, high_JJ cholesterol_NN ,_, diabetes_NN ,_, and_CC heart_NN disease_NN ,_,
each_DT of_IN which_WDT can_MD be_VB controlled_VBN with_IN safe_JJ medicines_NNS ._. 2_LS )_) The_DT mildly_RB overweight_NN
do_VBP n't_RB run_VB these_DT health_NN risks_NNS ,_, yet_RB drug_NN companies_NNS are_VBP using_VBG results_NNS from_IN 300_CD
pounders_NNS to_TO sell_VB drugs_NNS to_TO 140_CD pounders_NNS who_WP want_VBP to_TO look_VB good_JJ at_IN the_DT beach_NN ._. 3_LS )_)
Even_RB in_IN the_DT seriously_RB obese_NN ,_, we_PRP do_VBP n't_RB know_VB that_IN these_DT drugs_NNS really_RB will_MD save_VB
more_JJR than_IN they_PRP kill_VBP ,_, because_IN no_DT studies_NNS have_VBP been_VBN done_VBN ._. (_( Meanwhile_RB ,_, the_DT drug_NN
lobby_NN is_VBZ blocking_VBG the_DT FDA_NNP from_IN monitoring_VBG for_IN bad_JJ outcomes_NNS after_IN it_PRP approves_VBZ
drugs_NNS ._. )_)

            Fen-phen_NNP is_VBZ n't_RB our_PRP$ first_JJ
go-round_JJ with_IN a_DT miracle_NN cure_NN for_IN obesity_NN ,_, and_CC it_PRP is_VBZ n't_RB likely_JJ to_TO be_VB our_PRP$ last_JJ ._.
In_IN the_DT late_JJ '_POS 80_CD s_VBZ ,_, doctors_NNS inflated_VBD a_DT balloon_NN device_NN in_IN obese_NN patients_NNS '_POS
stomachs_NNS ._. Because_IN patients_NNS could_MD n't_RB eat_VB nearly_RB as_IN much_JJ ,_, they_PRP lost_VBD weight_NN and_CC
kept_VBD it_PRP off_RP ._. But_CC some_DT of_IN the_DT balloons_NNS deflated_VBN and_CC got_VBN stuck_VBN in_IN the_DT intestines_NNS ._.
Only_RB after_IN several_JJ people_NNS died_VBD was_VBD the_DT device_NN pulled_VBD off_IN the_DT market_NN ._. The_DT
dieters_NNS '_POS craving_NN for_IN something_NN to_TO quiet_VB their_PRP$ hunger_NN is_VBZ almost_RB as_RB great_JJ as_IN
their_PRP$ craving_NN for_IN food_NN ._.

         
      
   
